BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21744480)

  • 21. Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles.
    Lyapichev KA; Sukswai N; Konoplev S; Khoury JD
    Ann Hematol; 2019 Sep; 98(9):2221-2222. PubMed ID: 30955062
    [No Abstract]   [Full Text] [Related]  

  • 22. Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.
    Rauh MJ; Rahman F; Good D; Silverman J; Brennan MK; Dimov N; Liesveld J; Ryan DH; Burack WR; Bennett JM
    Leuk Res; 2012 Jan; 36(1):81-6. PubMed ID: 21890199
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Progressive violaceous nodules and plaques in an elderly man.
    Chapman LW; Hsiao JL; Lewis M; Chiu MW; Shellow WV
    Int J Dermatol; 2013 Oct; 52(10):1165-7. PubMed ID: 23834652
    [No Abstract]   [Full Text] [Related]  

  • 24. Blastic plasmacytoid dendritic cell neoplasm without cutaneous involvement: a rare disease with a rare presentation.
    Dantas FE; de Almeida Vieira CA; de Castro CC; Neto GC; Matos DM
    Acta Oncol; 2012 Jan; 51(1):139-41. PubMed ID: 21871006
    [No Abstract]   [Full Text] [Related]  

  • 25. CD4+ CD56+ haematodermic tumour (plasmacytoid dendritic cell neoplasm).
    Hamadani M; Magro CM; Porcu P
    Br J Haematol; 2008 Jan; 140(2):122. PubMed ID: 17991297
    [No Abstract]   [Full Text] [Related]  

  • 26. Blastic plasmacytoid dendritic cell neoplasm.
    Lim D; Goodman H; Rademaker M; Lamont D; Yung A
    Australas J Dermatol; 2013 May; 54(2):e43-5. PubMed ID: 23582004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumoral aspects of plasmacytoid dendritic cells: what do we know in 2009?
    Petrella T; Facchetti F
    Autoimmunity; 2010 Apr; 43(3):210-4. PubMed ID: 20166873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dermal infiltrates of cutaneous T-cell lymphomas with epidermotropism but not other cutaneous lymphomas are abundant with langerin⁺ dendritic cells.
    Der-Petrossian M; Valencak J; Jonak C; Klosner G; Dani T; Müllauer L; Pehamberger H; Knobler R; Trautinger F
    J Eur Acad Dermatol Venereol; 2011 Aug; 25(8):922-7. PubMed ID: 21054571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An atypical presentation of a blastic plasmacytoid dendritic cell tumors.
    López V; Martí N; Ferrández A; Martin JM; Jordá E
    J Cutan Pathol; 2010 Sep; 37(9):e50-2. PubMed ID: 19615025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excessive therapeutic response in a case of blastic plasmacytoid dendritic cell neoplasm.
    Shieh MP; Reisian N; Walavalkar V; Slater LM; Lambrecht N
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):56-9. PubMed ID: 22398810
    [No Abstract]   [Full Text] [Related]  

  • 31. Blastic plasmacytoid dendritic cell neoplasm without cutaneous lesion at presentation: case report and literature review.
    Wang H; Cao J; Hong X
    Acta Haematol; 2012; 127(2):124-7. PubMed ID: 22236870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic Plasmocytoid Dendritic Cell Neoplasm With Skin and Myeloid Location.
    Mizia-Malarz A; Sobol-Milejska G
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e29-e31. PubMed ID: 28060117
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blastic plasmacytoid dendritic cell neoplasm with t(2;8)(p12;q24).
    Seiwell AP; Buckley K; Pettenati M; Grier DD
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28097. PubMed ID: 31782605
    [No Abstract]   [Full Text] [Related]  

  • 34. TCL1 and CLA expression in agranular CD4/CD56 hematodermic neoplasms (blastic NK-cell lymphomas) and leukemia cutis.
    Petrella T; Meijer CJ; Dalac S; Willemze R; Maynadié M; Machet L; Casasnovas O; Vergier B; Teitell MA
    Am J Clin Pathol; 2004 Aug; 122(2):307-13. PubMed ID: 15323148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blastic Plasmacytoid Dendritic Cell Neoplasm: An Uncommon Entity to Consider in the Differential Diagnosis of Cutaneous Lymphoma.
    Aldera AP; van den Worm L; Locketz ML
    Int J Surg Pathol; 2020 Aug; 28(5):514-516. PubMed ID: 32054364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin lesions serve as clues to relapse of pediatric blastic plasmacytoid dendritic cell neoplasm.
    Dreyer S; Mednik S; Truong A; Worswick S; Scumpia P; Neill D; Kannan S; Hogeling M
    Pediatr Dermatol; 2018 Mar; 35(2):e132-e135. PubMed ID: 29436012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Blastic plasmacytoid dendritic cell neoplasm.
    Munoz J; Rana J; Inamdar K; Nathanson D; Janakiraman N
    Am J Hematol; 2012 Jul; 87(7):710. PubMed ID: 21953644
    [No Abstract]   [Full Text] [Related]  

  • 38. L-asparaginase with methotrexate and dexamethasone is an effective treatment combination in blastic plasmacytoid dendritic cell neoplasm.
    Gruson B; Vaida I; Merlusca L; Charbonnier A; Parcelier A; Damaj G; Royer B; Marolleau JP
    Br J Haematol; 2013 Nov; 163(4):543-5. PubMed ID: 23937331
    [No Abstract]   [Full Text] [Related]  

  • 39. Primary cutaneous blastic natural killer cell lymphoma.
    Parlette EC; Elliott JZ; Hall FW; Graham BS
    J Am Acad Dermatol; 2005 Oct; 53(4):742-3. PubMed ID: 16198814
    [No Abstract]   [Full Text] [Related]  

  • 40. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.